About this trial
Congenital heart disease (CHD) affects approximately 1% of live births, and children with CHD often fail to meet WHO physical activity guidelines. Digital interventions to promote physical activity in CHD patients are limited. This study will develop and test a 12-week digital lifestyle intervention for children (ages 8-13) and their guardians, using a Garmin Vivofit Jr. 2 wearable to continuously monitor physical activity (PA). We will assess its impact on children's moderate to vigorous intensity physical activity (MVPA), daily activity (steps per day), quality of life, nutrition, and health literacy, as well as the quality of life and health literacy of their parents.
Eligibility criteria
Qualifiers
Ages 8-14 years
Presence of a congenital heart defect (must be moderate or complex according to ACC criteria)
NYHA Class I or II
Presence of written informed consent
Disqualifiers
Cognitive impairments that inhibit patients from understanding the tasks
No sports clearance by paediatric cardiologists
Trial design
Treatments tested in this trial
- Digital Health Intervention
Treatment groups
Sponsors and collaborators
Deutsches Herzzentrum Muenchen
Lead sponsor
Technical University of Munich
Collaborator
Stiftung KinderHerz Deutschland gGmbH
Collaborator